These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7200929)

  • 1. Update on Dx and management of bladder cancer.
    Trump DL
    Geriatrics; 1982 Jul; 37(7):87-91. PubMed ID: 7200929
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer of the urogenital tract: bladder cancer. The accuracy of clinical vs. surgical staging.
    Baker R
    JAMA; 1968 Nov; 206(8):1770-3 passim. PubMed ID: 5754828
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combination of endoscopic resection and external radiotherapy in carcinoma of the bladder].
    Kahlain A; Bouras N; Sahraoui S; Acharki A; Benider A; Samlali R
    Cancer Radiother; 1998 Apr; 2 Suppl 1():31s-33s. PubMed ID: 9749075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Your patient with carcinoma of the urinary bladder. Options for organ preservation].
    Zaak D
    MMW Fortschr Med; 2003 Jan; 145(5):28-32. PubMed ID: 12619205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current practice of urinary bladder cytology.
    Frable WJ; Paxson L; Barksdale JA; Koontz WW
    Cancer Res; 1977 Aug; 37(8 Pt 2):2800-5. PubMed ID: 872107
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
    el-Ahmady O; Halim AB; el-Din AG
    Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder.
    Kundra V; Silverman PM
    AJR Am J Roentgenol; 2003 Apr; 180(4):1045-54. PubMed ID: 12646453
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Critical study of several histoprognostic factors concerning epidermoid type transitional cell carcinomas and vesical epidermoid carcinomas. Appropos of 107 cases].
    Lefèvre M; Crouzet T; Bouissou H
    Arch Anat Cytol Pathol; 1977; 25(4):277-82. PubMed ID: 603263
    [No Abstract]   [Full Text] [Related]  

  • 10. The cytologic diagnosis of transitional cell tumors of the urinary bladder and its histologic basis. A study of 567 cases of urinary-tract disorder including 170 untreated and 182 irradiated bladder tumors.
    Esposti PL; Moberger G; Zajicek J
    Acta Cytol; 1970 Mar; 14(3):145-55. PubMed ID: 4985639
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and treatment of bladder cancer.
    Sharma S; Ksheersagar P; Sharma P
    Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytologic diagnosis of occult and "in-situ" carcinoma of the urinary system.
    Allegra SR; Fanning JP; Streker JF; Corvese NM
    Acta Cytol; 1966; 10(5):340-9. PubMed ID: 5230228
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of carcinoma of the bladder: a summary.
    Jewett HJ
    Proc Natl Cancer Conf; 1970; 6():211-7. PubMed ID: 5458095
    [No Abstract]   [Full Text] [Related]  

  • 14. [Staining test with methylene blue during resection of bladder cancer in 30 patients].
    Jia WY; Li WL; Chen HG
    Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):351-3. PubMed ID: 7531137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial bladder cancer: part 1. Update on etiology, classification and natural history.
    Josephson DY; Pasin E; Stein JP
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1723-34. PubMed ID: 17181486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The surgical results in malignant bladder tumors using the Scalpel-1 carbon-dioxide laser].
    Dmitriev BV; Nikol'skiĭ AD; Latyshev MM; Zolin VP; Sanevich RA
    Urol Nefrol (Mosk); 1997; (1):25-8. PubMed ID: 9123661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current world literature. Bladder cancer.
    Curr Opin Urol; 2007 Sep; 17(5):378-80. PubMed ID: 17910129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.